Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia

BACKGROUND: Hepatitis C virus (HCV) non-structural protein 5A (NS5A) inhibitors have been recently developed to inhibit NS5A activities and have been approved for the treatment of HCV infection. However the drawback of these direct acting antivirals (DAAs) is the emergence of resistance mutations. T...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Virol J
Asıl Yazarlar: Aissa Larousse, Jameleddine, Trimoulet, Pascale, Recordon Pinson, Patricia, Tauzin, Brigitte, Azzouz, Mohamed Mssadak, Ben Mami, Nabyl, Cheikh, Imed, Triki, Henda, Fleury, Hervé
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4465297/
https://ncbi.nlm.nih.gov/pubmed/26047611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-015-0318-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller